Bunyavirales Infections

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".

Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 2869

Special Issue Editor


E-Mail Website
Guest Editor
Biotechnology Institute, Ankara, Turkey
Interests: viruses

Special Issue Information

Dear Colleagues,

The order Bunyavirales is one of the largest groups of RNA viruses encompassing major pathogens that infect humans, animals, and invertebrates (i.e., plants and insects). Because of their segmented genomes, members of the Bunyavirales are capable of a rapid recombination, which increases the risk that quasispecies can cause new outbreaks. Bunyaviruses that infect mammals are transmitted by vectors such as hematophagous arthropods (i.e., mosquitoes, midges, flies, and ticks) and various rodent species. In contrast, little is known about human-to-human transmission, except for phlebovirus infections. The viruses of the order Bunyavirales may cause few symptoms, but others may cause hemorrhagic fever, systemic infections, and even death in humans, and intrauterine infections in ruminants may result in various fetal pathologies such as births of malformed offspring and abortions, in addition to subclinical infections in adults.

In this Special Issue, we encourage researchers to submit articles addressing the viral hemorrhagic diseases caused by Bunyavirales, the pathogenesis of bunyavirus infections in veterinary medicine, epidemiological studies, virus–host and virus–vector interactions, immunity, vaccine candidates and their efficacy and effectiveness, and diagnostic tools.

Prof. Dr. Aykut Özkul
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bunyavirales
  • RNA viruses
  • bunyavirus
  • virus–vector interactions
  • immunity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1278 KiB  
Article
Hantavirus Pulmonary Syndrome Outbreak Anticipation by a Rapid Synchronous Increase in Rodent Abundance in the Northwestern Argentina Endemic Region: Towards an Early Warning System for Disease Based on Climate and Rodent Surveillance Data
by Ignacio Ferro, Walter Lopez, Flavia Cassinelli, Sara Aguirre, Griet A. E. Cuyckens, Sebastián Kehl, Daira Abán-Moreyra, Paola Castillo, Carla Bellomo, José Gil and Valeria P. Martinez
Pathogens 2024, 13(9), 753; https://doi.org/10.3390/pathogens13090753 - 2 Sep 2024
Viewed by 1208
Abstract
Hantavirus pulmonary syndrome (HPS) is an American emerging disease caused by the rodent-borne virus genus Orthohantavirus (Family: Hantaviridae: Order: Elliovirales Class: Bunyaviricetes). In Argentina, almost half of the HPS infections occur in the northwestern endemic region. In this study, we monitored [...] Read more.
Hantavirus pulmonary syndrome (HPS) is an American emerging disease caused by the rodent-borne virus genus Orthohantavirus (Family: Hantaviridae: Order: Elliovirales Class: Bunyaviricetes). In Argentina, almost half of the HPS infections occur in the northwestern endemic region. In this study, we monitored rodent abundance during 2022 and 2023 in three sites with different sampling methods (removal trapping, live trapping and hunted rodents by domestic cats) to evaluate their relationship with human infections. We found a similar pattern of variation in rodent abundance across time, and particularly a synchronous rise of rodent abundance that anticipated an HPS outbreak in 2023. Our dynamic regression models revealed a positive relationship between HPS cases and rodent abundance with a three-month lag, as well as rainfall with an eight-month lag. Our results provide a framework for the planning and implementation of public health prevention campaigns based on climatology and rodent monitoring. Domestic cats bringing rodents into houses can be an overlooked risk factor, particularly if viral shedding of infected rodents is magnified by stress. HPS is a disease of public health concern due to its high mortality rate, the lack of a specific therapeutic treatment and no vaccine. Thus, prevention of infections is of the utmost importance. Full article
(This article belongs to the Special Issue Bunyavirales Infections)
Show Figures

Figure 1

12 pages, 1945 KiB  
Article
Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis
by Jiansheng Huang, Ferdinard Adungo, Samson Limbaso Konongoi, Shingo Inoue, Lin Zhan, Rosemary Sang, Salame Ashur, Allan ole Kwallah, Matilu Mwau, Kouichi Morita and Fuxun Yu
Pathogens 2024, 13(7), 582; https://doi.org/10.3390/pathogens13070582 - 13 Jul 2024
Viewed by 1120
Abstract
Introduction: Rift Valley fever virus (RVFV) belonging to the Phenuiviridae family is responsible for a zoonotic disease called Rift Valley fever (RVF). Currently, RVFV has spread from Africa to Asia, and due to its ability to cause high mortality rates, it has significantly [...] Read more.
Introduction: Rift Valley fever virus (RVFV) belonging to the Phenuiviridae family is responsible for a zoonotic disease called Rift Valley fever (RVF). Currently, RVFV has spread from Africa to Asia, and due to its ability to cause high mortality rates, it has significantly impacted human health and economic development in many societies. Highly specific and sensitive systems for sero-diagnosis of RVFV infection are needed for clinical use. Method: BALB/c mice were immunized with recombinant RVFV nucleocapsid (rRVFV-N) protein and the spleen cells fused with SP2/0 myeloma cells to create hybridoma cell lines. The secreted monoclonal antibodies (MAbs) were purified and characterized. Enzyme-linked immunosorbent assay (ELISA) systems for the detection of IgG and IgM using the new MAbs were established and evaluated. Serum samples from 96 volunteers and 93 patients of suspected RVF from Kenya were tested compared with the ELISA systems based on inactivated viruses and the rabbit polyclonal antibody. Result: Three monoclonal antibodies against rRVFV-N protein were established. The performance of the MAb-based sandwich IgG ELISA and the IgM capture ELISA perfectly matched the ELISA systems using the inactivated virus or the polyclonal antibody. Conclusions: Recombinant RVFV-N protein-specific MAbs were developed and they offer useful tools for RVFV studies. The MAb-based ELISA systems for detecting IgG and IgM offer safe and useful options for diagnosing RVFV infections in humans. Full article
(This article belongs to the Special Issue Bunyavirales Infections)
Show Figures

Figure 1

Back to TopTop